Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$116.62
+2.2%
$100.08
$81.97
$137.49
$201.83B0.598.52 million shs9.83 million shs
Carnival Corporation stock logo
CCL
Carnival
$25.72
+1.4%
$27.87
$23.45
$34.03
$35.24B2.3518.08 million shs17.02 million shs
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
$17.27
+3.1%
$19.57
$14.53
$27.18
$7.92B1.916.18 million shs14.02 million shs
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$292.29
+1.6%
$304.42
$232.10
$366.50
$78.10B1.771.96 million shs1.49 million shs
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+4.81%+15.61%+33.40%-11.85%
Carnival Corporation stock logo
CCL
Carnival
0.00%-8.59%+1.59%-1.11%-12.05%
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
0.00%-9.11%-7.76%+5.96%-27.54%
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
0.00%-4.31%+2.93%+13.56%-11.12%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$116.62
+2.2%
$100.08
$81.97
$137.49
$201.83B0.598.52 million shs9.83 million shs
Carnival Corporation stock logo
CCL
Carnival
$25.72
+1.4%
$27.87
$23.45
$34.03
$35.24B2.3518.08 million shs17.02 million shs
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
$17.27
+3.1%
$19.57
$14.53
$27.18
$7.92B1.916.18 million shs14.02 million shs
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$292.29
+1.6%
$304.42
$232.10
$366.50
$78.10B1.771.96 million shs1.49 million shs
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+4.81%+15.61%+33.40%-11.85%
Carnival Corporation stock logo
CCL
Carnival
0.00%-8.59%+1.59%-1.11%-12.05%
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
0.00%-9.11%-7.76%+5.96%-27.54%
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
0.00%-4.31%+2.93%+13.56%-11.12%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.96
Moderate Buy$118.671.75% Upside
Carnival Corporation stock logo
CCL
Carnival
2.81
Moderate Buy$35.0836.40% Upside
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
2.30
Hold$21.0521.89% Upside
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
2.73
Moderate Buy$353.4020.91% Upside

Current Analyst Ratings Breakdown

Latest CCL, RCL, NCLH, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/18/2026
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
Boost Price TargetNeutral$17.00 ➝ $20.00
8/18/2026
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
Reiterated RatingOutperformNeutral$22.00 ➝ $17.00
8/18/2026
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
DowngradeHoldStrong Sell
8/18/2026
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
DowngradeOutperformNeutral$22.00 ➝ $17.00
8/13/2026
Carnival Corporation stock logo
CCL
Carnival
Reiterated RatingHold (C+)
8/13/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
UpgradePeer PerformOutperform$130.00
8/6/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
UpgradeSell (D+)Hold (C-)
8/4/2026
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
Reiterated RatingNeutral$17.00
8/3/2026
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
Reiterated RatingHold (C)
8/3/2026
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
Reiterated RatingBuy$367.00
7/31/2026
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
Set Price Target$17.00
(Data available from 8/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$44.33B4.55$6.99 per share16.69$29.91 per share3.90
Carnival Corporation stock logo
CCL
Carnival
$26.62B1.32$5.12 per share5.02$10.53 per share2.44
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
$9.83B0.81$4.67 per share3.70$5.60 per share3.08
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$17.94B4.36$22.40 per share13.05$39.11 per share7.47
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.0937.7419.182.2611.65%17.69%9.44%10/21/2026 (Estimated)
Carnival Corporation stock logo
CCL
Carnival
$2.76B$2.2211.599.891.0711.24%26.11%6.36%10/5/2026 (Estimated)
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
$423.25M$1.6010.7911.141.107.49%41.38%4.21%11/3/2026 (Estimated)
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$4.27B$16.1818.0614.531.0023.54%43.33%10.56%10/27/2026 (Estimated)

Latest CCL, RCL, NCLH, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
$0.4115$0.48+$0.0685$0.48$2.65 billion$2.64 billion
7/28/2026Q2 2026
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$3.98$4.21+$0.23$4.20$4.82 billion$4.83 billion
7/16/2026Q2 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.28$1.31+$0.03$0.53$12.52 billion$12.59 billion
6/23/2026Q2 2026
Carnival Corporation stock logo
CCL
Carnival
$0.3442$0.41+$0.0658$0.39$6.69 billion$6.66 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.16%+10.39%81.55%54 Years
Carnival Corporation stock logo
CCL
Carnival
$0.602.33%-100.00%27.03%N/A
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
N/AN/AN/AN/AN/A
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$6.002.05%+35.02%37.08%1 Years

Latest CCL, RCL, NCLH, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/8/2026
Carnival Corporation stock logo
CCL
Carnival
quarterly$0.152.07%8/7/20268/7/20268/28/2026
6/12/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.82%7/15/20267/15/20268/17/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.57
1.38
0.97
Carnival Corporation stock logo
CCL
Carnival
1.80
0.33
0.29
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
5.40
0.20
0.17
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
2.03
0.21
0.19

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Carnival Corporation stock logo
CCL
Carnival
67.19%
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
69.58%
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
87.53%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Carnival Corporation stock logo
CCL
Carnival
7.90%
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
0.25%
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
6.44%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.72 billionOptionable
Carnival Corporation stock logo
CCL
Carnival
101,0001.37 billion1.26 billionOptionable
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
44,500459.11 million457.96 millionOptionable
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
108,000267.45 million250.23 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$116.62 +2.48 (+2.17%)
As of 08/21/2026 03:58 PM Eastern

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Carnival stock logo

Carnival NYSE:CCL

$25.72 +0.35 (+1.38%)
As of 08/21/2026 03:58 PM Eastern

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Norwegian Cruise Line stock logo

Norwegian Cruise Line NYSE:NCLH

$17.27 +0.52 (+3.10%)
As of 08/21/2026 03:58 PM Eastern

Norwegian Cruise Line Holdings Ltd., together with its subsidiaries, operates as a cruise company in North America, Europe, the Asia-Pacific, and internationally. The company operates through the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands. It offers itineraries ranging from three days to a 180-days calling on various ports, including Scandinavia, Northern Europe, the Mediterranean, the Greek Isles, Alaska, Canada and New England, Hawaii, Asia, Tahiti and the South Pacific, Australia and New Zealand, Africa, India, South America, the Panama Canal, and the Caribbean. It distributes its products through retail/travel advisor and onboard cruise sales channels, as well as meetings, incentives, and charters. Norwegian Cruise Line Holdings Ltd. was founded in 1966 and is based in Miami, Florida.

Royal Caribbean Cruises stock logo

Royal Caribbean Cruises NYSE:RCL

$292.29 +4.67 (+1.62%)
As of 08/21/2026 03:58 PM Eastern

Royal Caribbean Cruises Ltd. operates as a cruise company worldwide. The company operates cruises under the Royal Caribbean International, Celebrity Cruises, and Silversea Cruises brands, which comprise a range of itineraries. As of February 21, 2024, it operated 65 ships. Royal Caribbean Cruises Ltd. was founded in 1968 and is headquartered in Miami, Florida.